Gene Query: ABI1

Dataset Description Geneva Score
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 22.94
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 22.69
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 22.69
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 16.43
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 16.33
Transcriptomic and gene ontology profiling of the human corneal cell types 16.13
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 16.05
SLAM-seq for K562 endogenous mRNA decay 15.41
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.93
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.93
Transcriptomic analysis of human tonsillar TFH subsets 14.09
The regulartory role of ZCCHC24 in splicing machinery 14.05
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 13.83
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 13.82
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 12.9
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 12.6
Unique features and clinical importance of acute alloreactive immune responses 12.53
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 12.48
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 12.35
Knockdown of ADNP in HCT116 colon cancer cells 12.09
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 12.08
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 11.71
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 11.65
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.51
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 11.25
Transcriptomic analyssis following EHMT1/2 inhibition 11.23
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 10.92
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.85
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.83
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 10.72
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.6
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 10.54
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.46
Human HAP1 cells before and after nutrient deprivation 10.41
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 10.41
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 10.4
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.39
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.33
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.27
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.26
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.97
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 9.51
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 9.44
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.41
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 9.36
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 9.33
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.28
Gene expression changes caused by KRAS in MCF-10A 9.12
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 9.06
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 9.05
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.82
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 8.74
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 8.67
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.56
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 8.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 8.45
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 8.36
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.36
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.3
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.24
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.96
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.91
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 7.87
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.85
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 7.81
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.76
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 7.72
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 7.66
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 7.59
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 7.57
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 7.53
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.49
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.46
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.43
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.39
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.33
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.32
RNA-seq differential expression studies: more sequence, or more replication? 7.31
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 7.28
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 7.28
The comparison of high-throughput single-cell RNA-seq methods 7.14
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.1
RIG-I and MDA5 fRIP during KSHV lytic reactivation 7.04
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  6.98
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.93
RNA-seq analysis and shRNA screen of breast cancer 6.89
RNA-seq analysis of breast cancer 6.89
hTERT promotes cell adhesion and migration independent of telomerase activity 6.87
Primary human trophoblast from term placenta 6.87
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.81
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 6.78
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 6.76
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 6.75
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.68
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.68
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 6.64
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.63
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.62
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 6.59
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 6.58
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 6.58
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.5
CROP-Seq in Primary Human T Cells 6.48
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 6.48
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.44
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 6.43
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 6.43
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 6.41
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 6.41
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 6.32
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.24
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.24
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 6.24
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 6.21
TCF7L1 knockdown in pancreatic cancer 6.2
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.17
Gene expression in PANC1 cells treated with Rakicidin 6.14
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 6.12
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.1
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 6.06
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.05
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.05
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 6.0
Human Treg NaCl stimulation 5.98
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 5.97
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.81
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.8
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.75
MYC dependent mRNA translation shapes gene expression and cell biology 5.75
RNAseq of HEK293 cells after Chtop knockdown 5.73
Co-transcriptional loading of RNA export factors shapes the human transcriptome 5.73
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.71
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.71
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.71
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.7
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.69
Functional role of CPPED1 in trophoblasts. 5.69
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 5.68
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.67
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.67
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.65
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.65
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.59
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.56
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.54
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 5.53
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 5.53
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 5.52
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 5.52
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.5
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.5
Genome-wide discovery of human splicing branchpoints 5.49
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 5.45
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 5.45
HBEC-shp53-PCHD7 5.44
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 5.41
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 5.4
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.36
Effect of Influenza virus infection on lncRNA expression in A549 cells 5.34
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.34
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 5.29
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 5.29
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 5.28
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 5.28
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 5.26
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 5.25
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.21
Depicting early human development and germ cell origin with porcine embryos 5.2
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.19
Transcriptome sequencing of K-562 cells 5.17
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.17
Survival of pancreatic cancer cells lacking KRAS function 5.17
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.16
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 5.15
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.14
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 5.14
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.14
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.13
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.1
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 5.1
CSL 5.09
CSL RNA-Seq on HKC and SCC cell lines 5.09
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 5.07
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 5.07
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 5.06
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.05
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.05
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 5.03
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 5.03
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.02
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.01
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 5.0
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.98
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.98
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 4.89
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 4.89
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.87
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.85
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.77
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.76
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.75
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 4.75
Transcriptional profiling of LS1034 cells treated with tepoxalin 4.73
SLIGRL-induced gene expression changes in NHEK cells 4.72
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.72
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.72
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.68
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.64
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.64
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.64
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.63
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 4.62
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 4.62
STRIPAK directs PP2A activity to promote oncogenic transformation 4.61
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.56
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.56
Differetially expressed genes after hTR overexpression in U2OS cells 4.5
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.5
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.5
Transcriptomes of oxLDL exposed trained monocytes 4.5
oxLDL exposed trained monocytes 4.5
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.48
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.48
Gene expression profiling of leukemia cells following asparagine depletion 4.45
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 4.4
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.39
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.38
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.37
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.37
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.36
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.36
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.34
The MEF2B Regulatory Network - RNA-seq data 4.3
The MEF2B Regulatory Network 4.3
Global gene expression profile of dasatinib-resistant RCH-ACV cells 4.25
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.25
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.19
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.14
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.13
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.12
Hypoxic transcriptome of SQ20B human head and neck cancer cells 4.09
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 4.05
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.05
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.05
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.01
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 3.97
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.97
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.91
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.9
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.86
HEK293 Heat-shock experiment 3.86
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.84
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.8
The Genetic Landscape of Diamond-Blackfan Anemia 3.8
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.78
STX4 Over-Expression in Human islets 3.78
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 3.77
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.76
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.76
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.71
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 3.71
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.69
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.69
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.64
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.64
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.63
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.61
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.61
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.6
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.59
RNA-Seq from human ILC transitional populations 3.59
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 3.59
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.59
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.53
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.51
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.51
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.51
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.48
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.48
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.48
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.44
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.44
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.42
Loss of CREBBP results in gene expression repression in lymphoma cells 3.42
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.41
Effect of from Human Umbilical Vein Endothelial Cells 3.39
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.39
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.38
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.37
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.35
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.35
Transcriptome analysis of peripheral blood monocytes 3.32
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.3
Be1 and Be2 B cells are transcriptionally distinct 3.28
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.25
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.25
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.24
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.23
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.2
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.18
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 3.14
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.13
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.13
Human Treg IL-12 stimulation 3.07
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.0
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.93
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.93
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.93
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.92
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.91
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.88
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 2.87
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.86
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.86
Mapping interactions for the TNIP2 hub protein 2.86
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.85
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.78
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.78
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.77
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.74
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.73
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.72
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.69
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 2.67
MARCKS and lnc-MARCKS act as inflammation regulators 2.66
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.6
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.52
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.5
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.5
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.49
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.48
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.47
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.43
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.43
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 2.43
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 2.43
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.37
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.36
Noncoding regions are the main source of targetable tumor-specific antigens 2.3
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.28
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.28
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.26
Hepatocyte maturation 2.25
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.25
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.21
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.18
The circadian transcriptional landscape in primary human mammary epithelial cells 2.18
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.18
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 2.17
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.15
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.15
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.14
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.13
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.12
Functional significance of the HIV-1 Tat signature amino acid residues 2.08
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.07
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.04
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 2.03
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.0
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.98
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.98
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.96
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.94
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.93
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.92
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.92
The transcriptome effect of overexpressing EZH2 in MCF7 1.91
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.9
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.88
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.85
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.83
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.82
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.82
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.81
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.77
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.73
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.73
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.68
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.68
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.67
Human optic chiasm from healthy controls and multiple sclerosis patients 1.66
Multiple sclerosis and EAE 1.66
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.66
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.66
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.64
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.64
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.63
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.62
Effect of nuclear IL-33 on gene expression 1.59
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.58
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.58
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.58
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.52
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.52
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.51
siRNA-mediated knockdown 1.47
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.46
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.46
Interaction between mitoNEET and NAF-1 in cancer cells 1.44
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.44
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.42
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 1.38
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.37
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.37
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.27
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.26
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.26
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.25
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.25
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.23
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.23
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.19
RNAseq analysis of ruxolitinib treated breast cancers 1.19
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.19
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.19
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.18
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.18
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.12
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.1
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.08
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.05
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.03
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.01
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.98
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 0.97
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.95
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.89
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.86
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.83
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.82
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.81
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.8
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.8
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.77
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.76
RNA-seq analysis of uveal melanoma cells treated with FR900359 0.75
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.75
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.72
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.72
RNA-seq data 0.7
RNA-seq of primary patient AML samples 0.67
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.66
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.63
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.62
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.62
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.58
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.58
MicroRNA-125a-5p overexpression in human macrophages 0.58
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.57
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.57
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.57
Aging-associated patterns in the expression of human endogenous retroviruses 0.56
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.55
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.52
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.5
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 0.49
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.48
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.47
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.45
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.45
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.43
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.43
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.37
Gene expression activation in CLL mediated by MSCs contact 0.34
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.33
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.33
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.3
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.3
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.3
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.29
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.27
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.26
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.26
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.24
Preclinical model of obesity and ER-positive breast cancer 0.23
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.23
6mer seed toxicity in viral microRNAs 0.22
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.21
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.21
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.19
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.19
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.18
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.16
Dermal endothelial cells of type 2 diabetic patients 0.16
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.14
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.12
Expression analysis of the TAF1 syndrome 0.12
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.11
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.11
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.06
RNA-seq of IL-4 stimulated human keratinocytes 0.04
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.03
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.03
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.03
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.02
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation